Arani Chanda

Arani Chanda is a Senior Scientific Advisor at Sudoc helping the team to bring the family of TAML catalysts to market in a variety of applications. Arani spent six years developing TAML catalysts with Dr. Terry Collins at Carnegie Mellon and has over ten years of professional experience in the pharmaceutical industry. At Sudoc, Arani will play a critical role in advancing the company’s mission to improve human and environmental health and well-being.

Pushing the boundaries in chemistry to improve the lives of many has been the central theme of Arani’s scientific endeavor for the last 20 years. Arani has spent time developing TAML catalysts with Dr. Terry Collins and in particular how oxidation technologies can clean water and find pathways to use water as a reaction media. He is currently involved in developing novel drugs for rare diseases at Serapta Therapeutics.